K. Itoh et al., CAPTOPRIL RENOSCINTIGRAPHY WITH TC-99M DTPA IN PATIENTS WITH SUSPECTED RENOVASCULAR HYPERTENSION PROSPECTIVE AND RETROSPECTIVE EVALUATION, Clinical nuclear medicine, 18(6), 1993, pp. 463-471
Sensitivity and specificity of captopril renoscintigraphy (CRS) with T
c-99m DTPA has been analyzed in 41 cases, 16 with renovascular hyperte
nsion (RVH) and 25 with non-RVH. The sensitivity and specificity of th
e baseline study were 63% (10/16) and 63% (12/19), respectively, based
on the split renal function study in which the lower limit of normal
was assumed to be 42% of the total renal uptake. Captopril renoscintig
raphy yielded 67% (12/18) sensitivity and 76% (19/25) specificity. The
low specificity of CRS was due to the application of a prospective cr
iterion of the captopril-induced reduction rate (CRR) of less than -20
%, which was calculated from the renal uptake before and after captopr
il. When criteria of CRR less than -25% were used, the specificity of
CRS was improved to 96%, but the sensitivity declined to 61%. Changes
in the configuration of the renogram induced by captopril also had hig
h specificity but low sensitivity. Renovascular hypertension was most
likely when criteria for both CRR and the renogram were fulfilled. The
se criteria often were diagnostic in patients with bilateral renal art
ery stenosis that showed variable scintigraphic responses to captopril
challenge. Captopril renoscintigraphy is a very specific means to eva
luate RVH, but may have limitations in certain clinical situations suc
h as poorly preserved function of the affected kidney, prior long-term
administration of captopril, prior surgical manipulation of stenotic
renal artery, and chronic renal parenchymal damage.